Author

S. Carl

Cleveland Clinic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Approach:deep learning· 2 Assay:electronic health records· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

C. Verdy· 1 shared D. Chowdhury· 1 shared F. Reizine· 1 shared I. Bezier· 1 shared J. Dulong· 1 shared J. Ferrant· 1 shared J. Feuillard· 1 shared J. M. Tadie· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Verdy

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CNN-based learning of single-cell transcriptomes reveals a blood-detectable multi-cancer signature of brain metastasis

R. Lusby, D. Chowdhury, S. Carl, V. K. Tiwari

The paper identifies a multi-cancer gene expression signature of brain metastasis using scRNA-seq and neural networks, detectable in blood-derived platelets.

bioRxiv · Mar 8, 2024 · PreprintCancer Biology

Machine Learning Electroencephalography Biomarkers Predictive of Epworth Sleepiness Scale

Matheus Araújo, Samer Ghosn, Lu Wang, Nengah Hariadi, Samantha Wells, S. Carl, Reena Mehra

This study uses machine learning to identify EEG biomarkers predictive of Epworth Sleepiness Scale scores, achieving over 80% accuracy in distinguishing high vs low ESS groups.

bioRxiv · Jun 29, 2022 · PreprintNeuroscience

Mass cytometry and artificial intelligence define CD169 as a specific marker of SARS-CoV2-induced acute respiratory distress syndrome

M. Roussel, J. Ferrant, F. Reizine, S. Le Gallou, J. Dulong, S. Carl, M. Lesouhaitier, M. Gregoire, N. Bescher, C. Verdy, M. Latour, I. Bezier, M. Cornic, S. Leonard, J. Feuillard, , K. Tarte

The paper identifies a specific immune signature in COVID-19-associated ARDS using mass cytometry and AI, showing it differs from other ARDS causes and is linked to adverse ICU outcomes.

bioRxiv · Sep 22, 2020Immunology